| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |